相关实验视频
Updated: Sep 19, 2025

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.5K
关于表皮细胞-介质细胞过渡和前列腺癌的研究进展
1Department of Urology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Frontiers in cell and developmental biology
|June 16, 2025
概括
前列腺癌 (PCa) 的进展,转移和耐药性与上皮-介质细胞过渡 (EMT) 有关. 这篇评论详细介绍了EMT的细节.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 前列腺癌 (PCa) 是全世界男性癌症死亡的主要原因.
- 转移性割抵抗性前列腺癌 (mCRPC) 提出了重大的治疗挑战和糟糕的患者结果.
- 表皮-介质细胞过渡 (EMT) 是一个细胞过程,与癌症进展有关.
研究的目的:
- 审查和综合最近关于EMT在前列腺癌进展中的作用的研究.
- 在PCa中巩固驱动EMT激活的分子机制.
- 阐明EMT如何促进PCa转移,复发和治疗耐药性.
主要方法:
- 关于前列腺癌中EMT的最新研究的综合文献综述.
- 在PCa中EMT激活的基础分子机制的分析.
- 巩固证据,将EMT与PCa进展和临床结果联系起来.
主要成果:
- EMT与PCa进展的关键方面密切相关,包括转移和复发.
- 激活EMT有助于免疫抑制瘤微环境的发展.
- 在前列腺癌中,EMT在获得的耐药性方面发挥着至关重要的作用.
结论:
- EMT是一个关键的细胞机制,驱动前列腺癌的攻击性特征.
- 了解EMT的分子基础对于开发PCa新型治疗策略至关重要.
- 针对EMT途径可能是一个有希望的方法来克服治疗耐药性,并改善高级PCa的结果.
相关概念视频
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K

